Researchers have achieved the mycosynthesis of copper oxide nanoparticles using cell-free extracts of Ganoderma lucidum, producing nanomaterials that demonstrate antioxidant, antimicrobial, and antihyperglycaemic activities. Reported by Meltem Tümer and Aslı Göçenoğlu Sarıkaya in BMC Chemistry, the study demonstrates that these biologically synthesized nanoparticles possess significant potential for future pharmaceutical and biomedical applications.
The mycosynthesis route for generating metal oxide nanoparticles provides several key advantages over conventional techniques, including eco-friendliness, non-toxicity, cost-effectiveness, and sustainability. Mycosynthesis of copper oxide nanoparticles was achieved using cell-free extracts of Ganoderma lucidum.
To evaluate the structural, morphological, and optical characteristics of the mycosynthesized nanoparticles, the authors applied a comprehensive suite of analytical instruments. The material was characterized using UV–Vis spectrophotometry, Fourier Transmission Infrared spectrometry, Scanning Electron Microscopy with Energy-Dispersive X-ray spectroscopy, Transmission Electron Microscopy, X-ray diffraction, and a Zeta sizer.
The microscopic and spectroscopic examinations determined that the synthesized copper oxide nanoparticles exhibited a regular polyhedral shape and a size distribution ranging between 20 and 40 nm. In addition, the Cu–O bond was observed at 597 cm−1.
The biological evaluation carried out on the mycosynthesized copper oxide nanoparticles established a profile of functional activities, specifically demonstrating antioxidant, antimicrobial, and antihyperglycaemic properties. Derived using cell-free extracts of Ganoderma lucidum, these nanoparticles exhibited measurable bioactivities that directly underpin their prospective utility in the biomedical and pharmaceutical sectors.
Subject of Research: Mycosynthesis and bioactivity of copper oxide nanoparticles from Ganoderma lucidum
Article Title: Antimicrobial, antioxidant, and antidiabetic activities of mycosynthesized copper oxide nanoparticles from Ganoderma lucidum
Article References: Tümer, M., & Göçenoğlu Sarıkaya, A. (2026). Antimicrobial, antioxidant, and antidiabetic activities of mycosynthesized copper oxide nanoparticles from Ganoderma lucidum. BMC Chemistry. https://doi.org/10.1186/s13065-026-01906-x
Image Credits: AI Generated
DOI: 10.1186/s13065-026-01906-x
Keywords: copper oxide nanoparticles, Ganoderma lucidum, mycosynthesis, cell-free extracts, metal oxide nanoparticles, antimicrobial activity, antioxidant activity, antihyperglycaemic activity, UV–Vis spectrophotometry, FTIR spectroscopy, SEM–EDS, transmission electron microscopy, X-ray diffraction, zeta sizer, polyhedral nanoparticles, biomedical applications
News Source: Bethany Barker. (November 14, 2026). Copper Oxide Nanoparticles from Ganoderma lucidum Display Antimicrobial and Antidiabetic Properties. Scienmag.



